Core Viewpoint - The company has provided a total guarantee of 249,850.00 million yuan for its subsidiaries, with a focus on maintaining manageable risk levels due to the good operational status of the guaranteed entities [2][10][13]. Summary by Sections Guarantee Overview - In August 2025, the company provided guarantees totaling 249,850.00 million yuan, with 185,350.00 million yuan for subsidiaries with a debt-to-asset ratio exceeding 70% and 64,500.00 million yuan for those below this threshold [2][10]. - As of August 31, 2025, the actual guarantee balance stood at 274.03 billion yuan, primarily for controlling subsidiaries and their subsidiaries, indicating a controlled risk environment [2][10]. Internal Decision-Making Process - The company held board meetings on December 8, 2024, and January 6, 2025, to approve the comprehensive credit plan for 2025, allowing guarantees for 141 companies and their subsidiaries [4][10]. - The guarantees can be adjusted internally among subsidiaries based on actual operational needs, ensuring flexibility in financial management [4][10]. Cumulative Guarantee Situation - The total external guarantees provided by the company and its subsidiaries amounted to 2,740,299.72 million yuan, exceeding 100% of the company's latest audited net assets [10][13]. - The company has not provided guarantees to controlling shareholders or related parties, maintaining a focus on its subsidiaries [10][13]. Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary for the daily operations of the subsidiaries, with the board confirming the repayment capabilities of the guaranteed entities [10][13]. - The company believes that the guarantees will not adversely affect shareholder interests and are essential for the normal conduct of business [10][13].
九州通医药集团股份有限公司关于为子公司提供担保的进展公告